Anand Bhaskar's Form 4 filing
Reata Pharmaceuticals Inc (RETA) · filed Aug 17, 2023
- Accession no.
- 0001209191-23-046276
- Filed
- Aug 17, 2023
- Trade date
- Aug 15-16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $68.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anand BhaskarCIK 0001890784 | Officer (SVP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Class A common stock | SSaleDisposed | −193 | $169.06 | −$32,628.58 | 24,705 | Direct | |
| Aug 16, 2023 | Class A common stock | SSaleDisposed | −210 | $168.42 | −$35,368.2 | 24,495 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.